A randomized, open-label phase 2 study of denintuzumab m

Project: Research project

Project Details

Description

mafodotin plus rituximab, ifosfamide, carboplatin, and etoposide chemotherapy vs. RICE in the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant
StatusFinished
Effective start/end date9/1/153/30/20

Funding

  • Seattle Genetics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.